Proteome Sciences plc (AIM:PRM)
1.770
+0.040 (2.31%)
Mar 6, 2026, 4:24 PM GMT
Proteome Sciences Revenue
Proteome Sciences had revenue of 1.86M GBP in the half year ending June 30, 2025, a decrease of -42.15%. This brings the company's revenue in the last twelve months to 4.53M, up 12.19% year-over-year. In the year 2024, Proteome Sciences had annual revenue of 4.89M, down -2.80%.
Revenue (ttm)
4.53M
Revenue Growth
+12.19%
P/S Ratio
1.34
Revenue / Employee
125.75K
Employees
36
Market Cap
6.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
| Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
| Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
| Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
| Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| OptiBiotix Health | 1.15M |
| Feedback | 849.62K |